ℹ️
🇨🇿
Hledání
Hledat publikace relevantní k dotazu "Memorial Sloan–Kettering Cancer Center risk"
Memorial Sloan–Kettering Cancer Center risk
Publikace
Předměty
Osoby
Publikace
Studium
publication
Outcomes According to MSKCC Risk Score with Focus on the Intermediate-Risk Group in Metastatic Renal Cell Carcinoma Patients Treated with First-Line Sunitinib: A Retrospective Analysis of 2390 Patients
2020 |
1. lékařská fakulta, Lékařská fakulta v Plzni
publication
Tyrosine kinase inhibitors in the first-line treatment for metastatic nonclear cell renal carcinoma: A retrospective analysis of a national database
2019 |
1. lékařská fakulta, Lékařská fakulta v Plzni
publication
Sorafenib Treatment of Advanced Renal Cell Carcinoma Patients in Daily Practice: The Large International PREDICT Study
2015 |
1. lékařská fakulta